Wikipedia -WSS

Wikipedia

author：fashion 2025-09-03 12:11:24 - browse：8988

FDA stop sign — Sarah Silbiger/Getty Images

The Food and Drug Administration is cracking down on websites that claim to sell the underlying chemicals of popular diabetes and obesity drugs like Ozempic, Wegovy, and Zepbound, saying that the websites are selling unapproved and misbranded drug products.

The regulator this week posted warning letters that it sent to two websites, Synthetix Inc. DBA Helix Chemical Supply and US Chem Labs. Though those websites say their chemicals are “for research use” and “not for human consumption,” the FDA said it found evidence on their pages showing that their products are indeed intended for human use, such as information about dosing and claims about the clinical benefits of the products.

The two websites did not immediately respond to requests for comment. The FDA said they have 15 working days to respond and detail the steps they’ve taken to address any violations.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Jerome Adams on the need for new antivirals for Covid
Next article： Bird flu in dairy cattle: New measures to control spread to humans

WSS

Illinois Supreme Court finds assault weapons ban constitutional

Sweeping indictment could be Trump's biggest legal challenge yet: ANALYSIS

Alzheimer's risk factor APOE4 may be a distinct form of the disease

Bird flu in dairy cattle: New measures to control spread to humans

Illumina slashes 2023 revenue projections yet again

Multiple sclerosis has subtypes with different best treatments: study

leisure time

Wikipedia

explore

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Maui wildfire now ranks as the fifth

Novavax promises a turnaround & Lilly roils the obesity market

Novo Nordisk touts Wegovy study, but still struggling with supply

Medicare proposal to cover medical devices draws a mixed reaction

Study: Black kids more likely to die after surgery than white kids

Continuity nursing helped my family in our darkest PICU moments

Health AI: on the border between health care and tech

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Gut bacteria may contribute to kidney autoimmunity, study finds

focus

Medicare Advantage 2025 payments will dip, Biden administration says

Florida Supreme Court upholds state's abortion ban

Surge in Apellis stock fueled by confidence in safety of its eye drug

Study: Black kids more likely to die after surgery than white kids

Mass General Brigham physicians react to latest merger step

Patients, digital health players weigh in on FTC's data privacy plan

explore

leisure time

focus

hotspot